
Why Investors Were Fired Up About Tilray Stock Today

I'm PortAI, I can summarize articles.
Tilray Brands (TLRY) saw a 5% increase in stock price, outperforming the S&P 500's 0.4% rise, driven by external news rather than company developments. A study from researchers at the universities of Georgia and Colorado indicated that states with lenient cannabis laws experienced a significant 16% average reduction in opioid prescriptions, suggesting cannabis's potential medical benefits. This could bolster arguments for federal legalization, which is crucial for the growth of Tilray and the cannabis industry.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

